STOCK TITAN

[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UNITED THERAPEUTICS Corp director Judy D. Olian reported the vesting of equity awards. On July 9, 2026, 1,310 Restricted Stock Units vested and converted on a one-for-one basis into 1,310 shares of common stock at an exercise price of $0.00 per share. Following this conversion, Olian holds 5,555 shares of common stock directly, and the reported Restricted Stock Unit position is reduced to zero. The transactions reflect compensation-related vesting, not an open‑market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Olian Judy D.
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Unit 1,310 -- --
Exercise Common Stock 1,310 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock — 5,555 shares (Direct)
Footnotes (1)
  1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Not applicable as restricted stock units do not have an expiration date.
RSUs vested and converted 1,310 units Restricted Stock Units vested and converted into common stock on July 9, 2026
Exercise/Conversion price $0.00 per share Conversion of Restricted Stock Units into common stock
Shares held after transaction 5,555 shares Common stock directly owned by Judy D. Olian after July 9, 2026 transactions
RSU balance after vesting 0 units Total Restricted Stock Units reported following the vesting and conversion
Restricted Stock Unit financial
"Shares received upon vesting of restricted stock units on July 9, 2026."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vesting financial
"Shares received upon vesting of restricted stock units on July 9, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
one-for-one basis financial
"Restricted stock units converted on a one-for-one basis into shares of common stock."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did UNITED THERAPEUTICS (UTHR) director Judy D. Olian report?

Judy D. Olian reported vesting of 1,310 Restricted Stock Units on July 9, 2026, which converted into 1,310 shares of common stock. This was a compensation-related derivative exercise/conversion, not an open-market trade.

How many UNITED THERAPEUTICS (UTHR) shares does Judy D. Olian hold after this Form 4?

After the July 9, 2026 transactions, Judy D. Olian directly holds 5,555 shares of common stock. These holdings reflect shares received from the conversion of 1,310 Restricted Stock Units and any prior holdings reported.

Were UNITED THERAPEUTICS (UTHR) shares bought or sold on the market in this Form 4?

No open-market buys or sells occurred. The filing shows a derivative exercise/conversion, where 1,310 Restricted Stock Units vested and converted into common stock at $0.00 per share as part of equity compensation.

What happened to Judy D. Olian’s Restricted Stock Units at UNITED THERAPEUTICS (UTHR)?

On July 9, 2026, 1,310 Restricted Stock Units vested and were converted on a one-for-one basis into 1,310 common shares. The reported Restricted Stock Unit balance after this vesting is 0 units.

Do the vested UNITED THERAPEUTICS (UTHR) Restricted Stock Units have an expiration date?

According to the filing footnote, an expiration date is not applicable to these Restricted Stock Units because they do not have an expiration date; instead, they vest and convert into common shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Olian Judy D.

(Last)(First)(Middle)
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET

(Street)
SILVER SPRING MARYLAND 20910

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/09/2026M(1)1,310A$0.00(1)5,555D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit$0.00(1)07/09/2026M(1)1,31007/09/2026 (2)Common Stock1,310(1)0.00D
Explanation of Responses:
1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.
2. Not applicable as restricted stock units do not have an expiration date.
Remarks:
/s/ John S. Hess, Jr. under Power of Attorney07/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)